The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
May 7th 2024
There is an extremely low rate of chronic obstructive pulmonary disease (COPD) diagnoses in Japan, particularly among patients with airflow obstruction, despite regular respiratory function tests.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
African American COPD Patients Underutilize Pulmonary Rehabilitation
May 21st 2019Researchers determined that African Americans were less likely to participate in pulmonary rehabiliation programs and examined whether the location of the nearest program had an effect on likelihood of participation.
Read More
New Computer App Could Predict Risk Factors for Adverse Outcomes of COPD Exacerbations
May 15th 2019A new computer application could easily and reliably predict the short-term risk of adverse outcomes and guide treatment options for patients with chronic obstructive pulmonary disease who visited an emergency department due to an exacerbation.
Read More
Eosinophil Counts Determine COPD-Related Healthcare Resource Utlization
May 15th 2019Blood eosinophil (EOS) counts of 150 cells/mcL or greater were associated with increased chronic obstructive pulmonary disease (COPD)–related healthcare resource utilization compared with EOS counts less than 150 cells/mcL, regardless of multiple inhaler triple therapy use.
Read More
Study Finds Suboptimal Adherence to GOLD Guidelines for COPD
May 9th 2019An analysis of adoption of and adherence to chronic obstructive pulmonary disease (COPD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in the primary care setting unearthed disappointing results, finding suboptimal use of pulmonary function tests, no routine use of validated symptoms scales for diagnosis, and variation in pharmacotherapy.
Read More
Azithromycin May Reduce Treatment Failure in Patients With Acute Exacerbation of COPD
May 3rd 2019A randomized controlled trial found that patients hospitalized for an acute exacerbation of chronic obstructive poulmonary disease (COPD) experienced reduced rates of treatment failure when adding azithromycin to their standard of care.
Read More
Comorbidities May Wipe Out Value of Follow-up Visits in Preventing Readmissions for COPD
May 1st 2019A new study has examined whether rapid follow-up appointments within 10 days of discharge affect the risk of readmission for patients with chronic obstructive pulmonary disease who experience acute exacerbations that lead to hospitalizations.
Read More
Unreported Exacerbations of COPD Could Affect Outcomes of Clinical Trials
April 24th 2019Unreported exacerbations of chronic obstructive pulmonary disease (COPD) in clinical trials may be more prevalent than researchers realize, and this could cause them to underestimate the frequency of clinically significant exacerbations. This could affect the conclusions studies reach about the effectiveness of treatments.
Read More
Study Identifies Gender Differences in Evaluation, Treatment, Outcomes Among Veterans With COPD
April 16th 2019Among veterans admitted to the hospital for chronic obstructive pulmonary disease (COPD) exacerbation, women were evaluated and treated differently than men prior to hospitalization and had better hospital-associated outcomes.
Read More
Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms
April 10th 2019Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.
Read More
E-cigarettes have become increasingly popular in the United States since their introduction in 2007. Reported use has dramatically increased among adults and, alarmingly, youths, as well. Sales of e-cigarettes, other vaping devices, and e-liquids have increased nearly 1400% over the last decade.
Read More
Integrated Disease Management Improves Clinical Outcomes, QOL in Patients With COPD in Primary Care
April 1st 2019By providing case management, self-management education, and skills training, integrated disease management is associated with fewer exacerbations and improved quality of life (QOL) among patients with chronic obstructive pulmonary disease (COPD) enagaged in primary care.
Read More
Lung Function Improved as Patients Increased Strenuous Daily Physical Activity, Study Says
March 27th 2019Individuals with an obstructive lung disease saw improvement in lung function when they replaced 30 minutes of sedentary time per day with strenuous or strength-building physical activity.
Read More
Adherence to COPD Treatment Lower With 3 Inhalers Compared With 2
March 20th 2019Patients with chronic obstructive pulmonary disease (COPD) had lower medication adherence when taking 3 inhalers compared with 2, suggesting that reducing the number of inhalers for these patients may improve adherence.
Read More
Damage to Dwellings and How You Cleaned Up Affected Respiratory Health After 9/11
March 14th 2019Exposure to dust from the collapse of the World Trade Center has been associated with a multitude of respiratory outcomes. For the first time, researchers looked at how dwellings in Lower Manhattan were damaged, how they were repaired, how people cleaned up afterwards, and how these differences affected the likelihood of respiratory symptoms and diseases.
Read More
e-Cigarettes Boost Heart Attack Risk, Emotional Stress, Findings Show
March 7th 2019Those who use e-cigarettes face higher risks of having a heart attack, experiencing emotional distress, and developing coronary artery disease compared to non-users, according to an abstract to be presented at the upcoming American College of Cardiology Scientific Sessions and Exposition in New Orleans, Louisiana.
Read More
Investigating Annual Variation in Exacerbation Frequency in Patients With COPD
March 6th 2019Analysis of a 2-year study showed that fluctuations in yearly chronic obstructive pulmonary disease (COPD) exacerbation rates may be associated with variations in Haemophilus influenzae colonization.
Read More
Exhaled Breath Condensate Containing Ultrafine Particles Marks COPD Damage
March 2nd 2019A recent study measured exhaled breath condensate (EBC) content that contained ultrafine particles (UFP) as a reflection of inflammation and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and as a marker of exacerbations.
Read More